First patient dosed with Transgenes TG6002 in colorectal cancer with liver metastases

First patient dosed with Transgene’s TG6002 in colorectal cancer with liver metastases

05:11 EST 21 Feb 2020 | Pharmaceutical Business Review

This procedure was performed at the NHS St James’s University Hospital in Leeds (United Kingdom). Dr. Adel Samson, Academic Medical Oncologist at The Leeds Teaching Hospitals NHS Trust

More From BioPortfolio on "First patient dosed with Transgene’s TG6002 in colorectal cancer with liver metastases"